Increased serum kallistatin levels in type 1 diabetes patients with vascular complications

Alicia J Jenkins, Jeffrey D McBride, Andrzej S Januszewski, Connie S Karschimkus, Bin Zhang, David N O'Neal, Craig L Nelson, Jasmine S Chung, C Alex Harper, Timothy J Lyons, Jian-Xing Ma

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

Kallistatin, a serpin widely produced throughout the body, has vasodilatory, anti-angiogenic, anti-oxidant, and anti-inflammatory effects. Effects of diabetes and its vascular complications on serum kallistatin levels are unknown.
Original languageEnglish
Pages (from-to)19
JournalJournal of angiogenesis research
Volume2
DOIs
Publication statusPublished - 2010

Fingerprint

Dive into the research topics of 'Increased serum kallistatin levels in type 1 diabetes patients with vascular complications'. Together they form a unique fingerprint.

Cite this